Moreover, we could demonstrate that expression of the immune checkpoint molecules CTLA-4, PD-1 and PD-L1 was increased on intratumoral and circulating T cells in HNSCC patients compared to healthy donors, reflecting an immunosuppressive tumor microenvironment. The gene discussed is PDCD1; the disease is neoplasm.